Research map: Potassium-competitive acid blockers for first-line Helicobacter pylori eradication: a systematic review and meta-analysis

Back to the article

Papers in this map

  1. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection · William D. Chey · 2017 · 1619 citations · Cited by this paper
  2. Regulation and function of Sox2 and CD44 expression in the stomach by Bone Morphogenetic Protein Signaling · 2026 · Related
  3. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report · Peter Malfertheiner · 2022 · 1513 citations · Cited by this paper
  4. The Gut-Brain Axis—From Science to Clinical Practice · 2026 · Related
  5. Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022 · Yi‐Chu Chen · 2024 · 536 citations · Cited by this paper
  6. Bilirubin-Driven Phenotype Identifies Higher Mortality Risk in Severe Alcohol-Associated Hepatitis · 2026 · Related
  7. Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus · Jyh‐Ming Liou · 2020 · 497 citations · Cited by this paper
  8. A Rare Cause of Gastrointestinal Bleeding: Endoscopic Resection of a Large Brunner Gland Hamartoma · 2026 · Related
  9. Helicobacter pylori Antibiotic Resistance in the United States Between 2011 and 2021: A Systematic Review and Meta-Analysis · Jonathan J. C. Ho · 2022 · 132 citations · Cited by this paper
  10. Hepatocyte HIF2α Downregulates the Urea Cycle Through Suppression of HNF4α · 2026 · Related
  11. IV Conferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pylori · Javier P. Gisbert · 2016 · 110 citations · Cited by this paper
  12. Risk Factors for Pouch Neoplasia in Patients with Inflammatory Bowel Disease: A Case-Control Study · 2026 · Related
  13. Rates of Antimicrobial Resistance in Helicobacter pylori Isolates From Clinical Trial Patients Across the US and Europe · Françis Mégraud · 2022 · 99 citations · Cited by this paper
  14. Artificial Intelligence for Anal Cancer Screening: Multicenter Multicontinental Validation of a Trinary Model in High-Resolution Anoscopy · 2026 · Related
  15. A comparison of efficacy and safety of potassium‐competitive acid blocker and proton pump inhibitor in gastric acid‐related diseases: A systematic review and meta‐analysis · Daniel Martin Simadibrata · 2022 · 92 citations · Cited by this paper
  16. Sequential Fibrosis-4 Index and Mac-2 Binding Protein Glycosylation Isomer Combination Improve Detection of Advanced Fibrosis in Metabolic Dysfunction–Associated Steatotic Liver Disease: A Multicenter Study · 2026 · Related
  17. AGA Clinical Practice Update on Integrating Potassium-Competitive Acid Blockers Into Clinical Practice: Expert Review · Amit C Patel · 2024 · 87 citations · Cited by this paper
  18. The Cardiovascular Risk Paradox in Normal-Weight Steatotic Liver Disease Beyond Body Mass Index–Based Detection · 2026 · Related
  19. Potassium-competitive acid blockers - are they the next generation of proton pump inhibitors? · Prashanth Rawla · 2018 · 73 citations · Cited by this paper
  20. Comparative Efficacy of Herbal Products on Metabolic Parameters in MASLD: A Systematic Review and Network Meta-Analysis · 2026 · Related
  21. Eradication rates of Helicobacter pylori in treatment‐naive patients following 14‐day vonoprazan‐amoxicillin dual therapy: A multicenter randomized controlled trial in China · Jie Hu · 2023 · 60 citations · Cited by this paper
  22. Quadruple therapy with vonoprazan 20 mg daily as a first‐line treatment for Helicobacter pylori infection: A single‐center, open‐label, noninferiority, randomized controlled trial · Lifen Lu · 2022 · 55 citations · Cited by this paper
  23. Ten-Day Vonoprazan-Amoxicillin Dual Therapy vs Standard 14-Day Bismuth-Based Quadruple Therapy for First-Line Helicobacter pylori Eradication: A Multicenter Randomized Clinical Trial · Tian‐Lian Yan · 2023 · 52 citations · Cited by this paper
  24. Treatment of Helicobacter pylori with potassium competitive acid blockers: A systematic review and meta-analysis · Joseph Edwin Kanu · 2024 · 49 citations · Cited by this paper
  25. Efficacy of tegoprazan‐based bismuth quadruple therapy compared with bismuth quadruple therapy for Helicobacter pylori infection: A randomized, double‐blind, active‐controlled study · Joon Sung Kim · 2023 · 46 citations · Cited by this paper
  26. Combination of vonoprazan and amoxicillin as the first-line Helicobacter pylori eradication therapy: a multicenter, prospective, randomized, parallel-controlled study · Xiang Peng · 2023 · 44 citations · Cited by this paper
  27. Efficacy and safety of vonoprazan–amoxicillin dual therapy for Helicobacter pylori first-line treatment: a single-center, randomized, controlled trial · Xiaolei Wang · 2023 · 35 citations · Cited by this paper
  28. Efficacy and safety of potassium-competitive acid blockers versus proton pump inhibitors as Helicobacter pylori eradication therapy: a meta-analysis of randomized clinical trials · Mengran Zhang · 2022 · 28 citations · Cited by this paper
  29. A Modified 14-Day Dual Therapy with Vonoprazan and Amoxicillin Amplified the Advantages Over Conventional Therapies for Eradication of Helicobacter pylori: A Non-Inferiority Clinical Trial · Juan Li · 2023 · 26 citations · Cited by this paper
  30. A randomized clinical study on the efficacy of vonoprazan combined with amoxicillin duo regimen for the eradication of Helicobacter pylori · Faming Yang · 2023 · 26 citations · Cited by this paper
  31. Vonoprazan Dual or Triple Therapy Versus Bismuth‐Quadruple Therapy as First‐Line Therapy for Helicobacter pylori Infection: A Three‐Arm, Randomized Clinical Trial · Ka Shing Cheung · 2024 · 26 citations · Cited by this paper
  32. Comparative Efficacy and Safety of Potassium-Competitive Acid Blocker-Based Dual, Triple, and Quadruple Regimens for First-Line Helicobacter pylori Infection Treatment: A Systematic Review and Network Meta-Analysis · Theodore Rokkas · 2024 · 25 citations · Cited by this paper
  33. Update on the first-line treatment of Helicobacter pylori infection in areas with high and low clarithromycin resistances · Chih‐An Shih · 2022 · 23 citations · Cited by this paper
  34. A scoping review of worldwide guidelines for diagnosis and treatment of Helicobacter pylori infection · Mingyao Sun · 2025 · 23 citations · Cited by this paper
  35. P-CAB versus PPI in the eradication of Helicobacter pylori : a systematic review and network meta-analysis · Yutong Jiang · 2024 · 22 citations · Cited by this paper
  36. Vonoprazan on the Eradication of Helicobacter pylori Infection · Jiaming Huang · 2022 · 21 citations · Cited by this paper
  37. Tegoprazan‐Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Prospective, Randomized, Multicenter Study in Fujian, China · Xueyan Lin · 2024 · 21 citations · Cited by this paper
  38. Potassium-Competitive Acid Blocker and Proton Pump Inhibitor–Based Regimens for First-Line Helicobacter pylori Eradication: A Network Meta-Analysis · Peter Malfertheiner · 2022 · 18 citations · Cited by this paper
  39. Vonoprazan-amoxicillin dual therapy for Helicobacter pylori eradication in Chinese population: A prospective, multicenter, randomized, two-stage study · Xueping Huang · 2024 · 18 citations · Cited by this paper

Source: OpenAlex (CC0)